CCL11 and Stroke: The therapeutic potential of the CCL11 pathway under ischemic conditions is underscored by using the CCL11 inhibitor SB297006, which not only reverses the CCL11-induced aggravation of brain injury but also yields neuroprotection in adult stroke mice.